Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study

[1]  Jun Li,et al.  Epigenetic mechanisms in atrial fibrillation: New insights and future directions. , 2016, Trends in cardiovascular medicine.

[2]  Sudha Seshadri,et al.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study , 2015, The Lancet.

[3]  K. Lunetta,et al.  Whole blood gene expression and interleukin-6 levels. , 2014, Genomics.

[4]  K. Lunetta,et al.  Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation , 2014, Circulation.

[5]  C. Gieger,et al.  DNA methylation and body-mass index: a genome-wide analysis , 2014, The Lancet.

[6]  K. Lunetta,et al.  Whole Blood Gene Expression and Atrial Fibrillation: The Framingham Heart Study , 2014, PloS one.

[7]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[8]  Baoshan Ma,et al.  Predicting DNA methylation level across human tissues , 2014, Nucleic acids research.

[9]  David M Herrington,et al.  Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.

[10]  Andrew D. Johnson,et al.  Gene Expression Signatures of Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Ruth Pidsley,et al.  A data-driven approach to preprocessing Illumina 450K methylation array data , 2013, BMC Genomics.

[12]  David D. McManus,et al.  Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium , 2013, Journal of the American Heart Association.

[13]  Elsayed Z Soliman,et al.  Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. , 2013, JAMA internal medicine.

[14]  K. Lunetta,et al.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation , 2012, Nature Genetics.

[15]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[16]  Lesley H. Curtis,et al.  Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007 , 2012, Circulation. Cardiovascular quality and outcomes.

[17]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[18]  Jacob F. Degner,et al.  Sequence and Chromatin Accessibility Data Accurate Inference of Transcription Factor Binding from Dna Material Supplemental Open Access , 2022 .

[19]  Emmanouil Collab.  A map of human genome variation from population-scale sequencing , 2011, Nature.

[20]  Maria Toledo-Rodriguez,et al.  Maternal smoking during pregnancy is associated with epigenetic modifications of the brain‐derived neurotrophic factor‐6 exon in adolescent offspring , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  I. Gromova,et al.  Human BLCAP transcript: new editing events in normal and cancerous tissues , 2009, International journal of cancer.

[22]  L. Groop,et al.  Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes , 2009, Diabetes.

[23]  G. Lund,et al.  Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteine. , 2009, Current opinion in lipidology.

[24]  Eric Boerwinkle,et al.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.

[25]  M. Nesline,et al.  Association between global DNA hypomethylation in leukocytes and risk of breast cancer , 2009, Carcinogenesis.

[26]  O. Olivieri,et al.  Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. , 2008, Atherosclerosis.

[27]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[28]  Donald M Bers,et al.  Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. , 2007, Cardiovascular research.

[29]  J. Tolstrup,et al.  Alcohol Consumption and Risk of Atrial Fibrillation in Men and Women: The Copenhagen City Heart Study , 2005, Circulation.

[30]  C. Gallou-Kabani,et al.  Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. , 2005, Diabetes.

[31]  Owen W. Ryan,et al.  Conserved and specific functions of mammalian ssu72 , 2005, Nucleic acids research.

[32]  F. Frey,et al.  Epigenetic regulation of 11β-hydroxysteroid dehydrogenase type 2 expression , 2004 .

[33]  P. Vestergaard,et al.  Alcohol and risk of atrial fibrillation or flutter: a cohort study. , 2004, Archives of internal medicine.

[34]  D. Levy,et al.  Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. , 2004, The American journal of cardiology.

[35]  F. Frey,et al.  Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. , 2004, The Journal of clinical investigation.

[36]  D. Fitzpatrick,et al.  Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. , 2003, Clinical immunology.

[37]  S. Ylä-Herttuala,et al.  DNA methylation, smooth muscle cells, and atherogenesis. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[38]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[39]  R. Hewick,et al.  Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. , 2003, Molecular endocrinology.

[40]  Jörg Striessnig,et al.  Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[42]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[43]  K. Mishra-Gorur,et al.  The S18 Ribosomal Protein Is a Putative Substrate for Ca2+/Calmodulin-activated Protein Kinase II* , 2002, The Journal of Biological Chemistry.

[44]  S. Maier,et al.  Diabetes: a candidate disease for efficient DNA methylation profiling. , 2002, The Journal of nutrition.

[45]  A. Monneron,et al.  Striatin, a calmodulin‐dependent scaffolding protein, directly binds caveolin‐1 , 2001, FEBS letters.

[46]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[47]  C. Plass,et al.  Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. , 2000, Cardiovascular research.

[48]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[49]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[50]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[51]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[52]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[53]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[54]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[55]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.